A 38-year-old man with type 2 diabetes presents with severe hypoglycemia (blood glucose 45 mg/dL) during an outpatient clinic visit. He is conscious and able to swallow. Physical examination shows tremor and diaphoresis. You recognize that glucagon, the emergency treatment, works via cAMP-dependent signaling in hepatocytes. Which is the most appropriate immediate next step in management?

Explanation

## Acute Hypoglycemia Management — Conscious Patient Able to Swallow **Key Point:** In a conscious patient who is able to swallow, the **first-line immediate treatment** for symptomatic hypoglycemia is oral fast-acting carbohydrates (glucose tablets or juice), following the "Rule of 15." ### Why Oral Glucose is Correct This patient is **conscious and able to swallow** with a blood glucose of 45 mg/dL and mild-to-moderate symptoms (tremor, diaphoresis). Per ADA guidelines and standard clinical practice: - **Oral glucose (15–20 g fast-acting carbohydrates)** is the recommended first-line treatment for conscious patients who can swallow safely - Reassess blood glucose in **15 minutes** (Rule of 15); repeat if still < 70 mg/dL - Oral glucose is safe, effective, and avoids unnecessary invasive procedures in a cooperative patient ### Why the Other Options Are Incorrect - **Option B (IM glucagon):** Reserved for patients who are **unconscious, unable to swallow, or uncooperative**. This patient is conscious and can swallow, making IM glucagon unnecessary and more invasive than required. - **Option C (IV dextrose 50%):** Reserved for patients with **severe hypoglycemia with altered consciousness** or those without IV access who cannot take oral glucose. Using IV dextrose in a conscious, swallowing patient is overly aggressive and not guideline-recommended as the *immediate* first step. - **Option D (defer treatment):** Dangerous — symptomatic hypoglycemia requires immediate treatment; deferring risks rapid neurological deterioration. ### Biochemical Context The stem references glucagon's cAMP-dependent mechanism (glucagon → Gs-coupled GPCR → adenylyl cyclase → ↑cAMP → PKA activation → glycogenolysis/gluconeogenesis in hepatocytes) to illustrate why pharmacological glucagon is an option in hypoglycemia. However, this pathway is **slower and more invasive** than simply providing oral glucose to a cooperative patient. **High-Yield (Harrison's Principles of Internal Medicine):** The treatment algorithm for hypoglycemia prioritizes the least invasive effective intervention: oral carbohydrates first in conscious patients → IM glucagon or IV dextrose for unconscious/unable-to-swallow patients. **Clinical Pearl:** Always match the intervention to the patient's clinical status. A conscious, swallowing patient with hypoglycemia should receive oral glucose first — IV dextrose and IM glucagon are escalation options for more severe or uncooperative presentations.